Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on the Effectiveness of Valganciclovir for Patients with Glioblastoma
NorwayOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
AustriaStudy of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations
ItalyStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
CzechiaStudy of aneratrigine mesilate (iN1011-N17-02) to find the best dose for treating pain in adults with post-herpetic neuralgia
BulgariaStudy of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years
DenmarkStudy on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older
FinlandStudy on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury
AustriaStudy on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy
GermanyStudy on the Effects of ION363 for Patients with Amyotrophic Lateral Sclerosis with Fused in Sarcoma Mutations
BelgiumStudy on the Effects and Safety of Ginkgo Biloba Extract in Patients with Cognitive Impairment After COVID-19
GermanyStudy on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
